Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. Company
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Moderna, Inc.
Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for infectious, autoimmune and cardiovascular diseases. Turnover per type of income can be broken down as follows:

- Collaboration revenue (79.8%);

- Grant revenue (20.2%).

At the end of 2019, the group possessed a portfolio of 6 development candidates in clinical studies, with three in phase II and three in phase I.

Number of employees : 1 300 people.
Sales per Business
20192020Delta
Transformative Medicines60.21100%803.40100% +1234.34%
USD in Million
Sales per region
2020
United States764.5395.2%
Rest of World38.874.8%
USD in Million
Managers
Name Title Age Since
StÚphane Bancel Chief Executive Officer & Director 47 2011
Stephen Hoge President 44 2015
David Meline Chief Financial Officer 62 2020
Juan Andres Chief Technical Operations & Quality Officer 55 2017
Paul Burton Chief Medical Officer - 2021
Paul Sagan Independent Non-Executive Director 61 2018
Robert Langer Independent Non-Executive Director 71 2010
Stephen A. Berenson Independent Non-Executive Director 59 2017
Noubar Afeyan Chairman 58 2012
Francois Nader Independent Non-Executive Director 63 2019
Members of the board
Name Title Age Since
Noubar Afeyan Chairman 58 2012
Paul Sagan Independent Non-Executive Director 61 2018
Robert Langer Independent Non-Executive Director 71 2010
Stephen A. Berenson Independent Non-Executive Director 59 2017
StÚphane Bancel Chief Executive Officer & Director 47 2011
Francois Nader Independent Non-Executive Director 63 2019
Sandra J. Horning, Dr. Independent Director 71 2020
Elizabeth E. Tallett Independent Director 71 2020
Elizabeth G. Nabel, Dr. Independent Director 68 2021
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 405,449,527 366,799,596 90.5% 0 0.0% 90.5%
Shareholders
NameEquities%
Baillie Gifford & Co. 42,217,354 10.5%
The Vanguard Group, Inc. 25,705,125 6.37%
StÚphane Bancel 22,138,787 5.48%
Flagship Pioneering 17,581,016 4.36%
SSgA Funds Management, Inc. 13,957,581 3.46%
Robert Langer 11,509,357 2.85%
BlackRock Fund Advisors 7,588,443 1.88%
Coatue Management LLC 6,048,926 1.50%
Geode Capital Management LLC 5,759,961 1.43%
Fidelity Management & Research Co. LLC 5,142,172 1.27%
Markets and indexes
- Nasdaq Global Select Market
- Nasdaq 100 /
Stock Exchange Codes
- Bloomberg Code :  
- Reuters Code :  MRNA.O
- Datastream Code :  
Company contact information
Moderna, Inc.
200 Square Technology
MA 02139 Cambridge, Massachusetts

Phone : +1 617 714 6500
Fax : +1 617 583 1998
web site : https://www.modernatx.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Moderna, Inc.